Erythropoietin (EPO)—a key regulator of red blood cell production—is widely used for treating certain cancers and anemia induced by chronic kidney disease. However, the time that EPO resides in the bloodstream depends ...
Biotechnology
Jun 4, 2014
0
0
(Phys.org)—Researchers in the group of Centennial Professor of Chemistry, Samuel Danishefsky, have synthesized what is arguably the largest and most complex biological molecule ever assembled by the methods of organic chemistry. ...
Biochemistry
Nov 12, 2012
0
0
Drug companies often use yeast to manufacture drugs, especially proteins such as antibodies and enzymes. It has been assumed that a batch of genetically identical yeast will secrete such drugs at uniform rates, but MIT chemical ...
Biotechnology
Mar 26, 2010
1
0
Healthy young mice treated with erythropoietin show lasting improved performance in learning and other higher brain functions. Researchers writing in the open access journal BMC Biology tested the cognitive effects of the ...
Other
Jul 8, 2009
1
1
Erythropoietin, or its alternatives erythropoetin or erithropoyetin ( /ɨˌrɪθrɵˈpɔɪ.ɨtɨn/, /ɨˌrɪθrɵˈpɔɪtən/, or /ɨˌriːθrɵ-/) or EPO, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine for erythrocyte (red blood cell) precursors in the bone marrow.
Also called hematopoietin or hemopoietin, it is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and tubular epithelial cells. It is also produced in perisinusoidal Ito cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. Erythropoietin is the hormone that regulates red blood cell production. It also has other known biological functions. For example, erythropoietin plays an important role in the brain's response to neuronal injury. EPO is also involved in the wound healing process.
When exogenous EPO is used as a performance-enhancing drug, it is classified as an erythropoiesis-stimulating agent (ESA). Exogenous EPO can often be detected in blood, due to slight difference from the endogenous protein, for example in features of posttranslational modification.
This text uses material from Wikipedia, licensed under CC BY-SA
